This topic contains a solution. Click here to go to the answer

Author Question: A client is prescribed to receive three 360 mL cans of a dietary supplement every day. How many ... (Read 92 times)

bb

  • Hero Member
  • *****
  • Posts: 544
A client is prescribed to receive three 360 mL cans of a dietary supplement every day. How many pints of the dietary supplement will the client ingest in a week?
 
  1. 12 4/17
  2. 13 5/11
  3. 15 3/25
  4. 17 11/13

Question 2

A client is prescribed to receive 0.12 liters of a liquid preparation every 6 hours. When at home, how many tablespoons of the medication should the client take to equal this amount?
 
  1. 6
  2. 8
  3. 10
  4. 12



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bubulittle310@msn.cn

  • Sr. Member
  • ****
  • Posts: 281
Answer to Question 1

3

Rationale 1: Pints/week = 1 pint/500 mL x 360 mL/1 can x 3 cans/1 day x 7 days/1 week. Multiply the numerators (1 x 360 x 3 x 7 = 7560). Multiply the denominators (500 x 1 x 1 x 1= 500). 7560/500 = 15.12 (12/100 = 3/25) = 15 3/25

Answer to Question 2

2

Rationale 1: T of liquid preparation = 1 T/15 mL x 1000 mL/1 L x 0.12 L/1. Multiply the numerators (1 x 1000 x 0.12 = 120). Multiply the denominators (15 mL x 1 x 1 = 15). 120/15 = 8 T.





 

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library